Your browser doesn't support javascript.
loading
Effect of age on in-hospital outcomes of transvenous lead extraction for infected cardiac implantable electronic device.
Tan, Min Choon; Ang, Qi Xuan; Yeo, Yong Hao; Thong, Jia Yean; Tolat, Aneesh; Scott, Luis R; Lee, Justin Z.
Afiliación
  • Tan MC; Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, Arizona, USA.
  • Ang QX; Department of Internal Medicine, New York Medical College at Saint Michael's Medical Center, Newark, New Jersey, USA.
  • Yeo YH; Department of Internal Medicine, Sparrow Health System and Michigan State University, East Lansing, Michigan, USA.
  • Thong JY; Department of Internal Medicine/Pediatrics, Beaumont Health, Royal Oak, Michigan, USA.
  • Tolat A; Fudan University Shanghai Medical College, Shanghai, China.
  • Scott LR; Department of Cardiovascular Medicine, Hartford Healthcare/University of Connecticut, Hartford, Connecticut, USA.
  • Lee JZ; Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, Arizona, USA.
Pacing Clin Electrophysiol ; 47(4): 577-582, 2024 04.
Article en En | MEDLINE | ID: mdl-38319639
ABSTRACT

BACKGROUND:

The real-world data on the safety profile of transvenous lead extraction (TLE) for infected cardiac implantable electronic devices (CIED) among elderly patients is not well-established. This study aimed to evaluate the hospital outcomes between patients of different age groups who underwent TLE for infected CIED.

METHOD:

Using the Nationwide Readmissions Database, our study included patients aged ≥18 years who underwent TLE for infected CIED between 2017 and 2020. We divided the patients into four groups Group A. Young (<50 years), Group B. Young intermediate (50-69 years old), Group C. Older intermediate (70-79 years old), and Group D. Octogenarian (≥80 years old). We then analyzed the in-hospital outcome and 30-day readmission between these age groups.

RESULTS:

A total of 10,928 patients who were admitted for TLE of infected CIED were included in this study 982 (9.0%) patients in group A, 4,234 (38.7%) patients in group B, 3,204 (29.3%) patients in group C and 2,508 (23.0%) of patients in group D. Our study demonstrated that the risk of early mortality increased with older age (Group B vs. Group A OR 1.92, 95% CI 1.19-3.09, p < .01; Group C vs. Group A OR 2.47, 95% CI 1.51-4.04, p < .01; Group D vs. Group A OR 2.82, 95% CI 1.69-4.72, p < .01). The risk of non-home discharge also increased in elderly groups (Group B vs. Group A OR 1.89; 95% CI 1.52-2.36; p < .01; Group C vs. Group A OR 2.82; 95% CI 2.24-3.56; p < .01; Group D vs. Group A OR 4.16; 95% CI 3.28-5.28; p < .01). There was no significant difference in hospitalization length and 30-day readmission between different age groups. Apart from a higher rate of open heart surgery in group A, the procedural complications were comparable between these age groups.

CONCLUSION:

Elderly patients had worse in-hospital outcomes in early mortality and non-home discharge following the TLE for infected CIED. There was no significant difference between elderly and non-elderly groups in prolonged hospital stay and 30-day readmission. Elderly patients did not have a higher risk of procedural complications.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Marcapaso Artificial / Desfibriladores Implantables Límite: Adolescent / Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Revista: Pacing Clin Electrophysiol Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Marcapaso Artificial / Desfibriladores Implantables Límite: Adolescent / Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Revista: Pacing Clin Electrophysiol Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos